Codexis signs evaluation agreement with Axolabs

Codexis (CDXS) and Axolabs, part of LGC Group, an oligonucleotide Contract Research Development and Manufacturing organization, announced that they have entered into an agreement under which Axolabs will evaluate Codexis’ ECO Synthesis Manufacturing Platform. This partnership provides Axolabs access to an innovative, scalable RNA manufacturing solution powered by enzymatic synthesis. The Agreement paves the way for future licensing discussions and potentially broader adoption of the platform.